Testosterone pellet insertion on TikTok: what's actually happening
Quick answer
The video documents a subcutaneous testosterone pellet insertion for a perimenopausal woman, a procedure that involves implanting compounded testosterone pellets in the upper gluteal area under local anesthesia. The provider states a dose of "150 grams," which is almost certainly a verbal error for 150 milligrams, a figure within the reported female dosing range but on the higher end. Duration of effect for subcutaneous pellets in women typically ranges from three to six months, influenced by metabolic rate and physical activity levels.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @nataliemurray75 actually say?
Natalie filmed her testosterone pellet insertion appointment with Dr. Rockhead, capturing the procedure in real time. The most specific clinical claim came from her provider: "based on your weight, we're going to give you 150 grams of testosterone." She also relayed that the pellets "last about six months," with a caveat that her active lifestyle might shorten that window. She described the procedure as painless, finishing in under two minutes, and walked out with a bandage the size of a postage stamp.
The video is largely experiential rather than instructional, which limits some of the harm potential. Still, two specific claims, the dosing figure and the six-month duration, deserve scrutiny because they're the kind of numbers viewers screenshot and bring into their own doctor's appointments.
Does the science back this up?
The six-month duration claim is broadly supported for subcutaneous pellets, but the dosing figure has a serious problem. The transcript says "150 grams," which is not a real clinical dose. That figure is almost certainly a transcription or speech error for 150 milligrams, a number that sits within reported ranges for women. But the distinction matters.
Studies on testosterone pellet therapy in women, including Davis et al. (2019, Lancet Diabetes and Endocrinology), report typical female dosing in the range of 50-150 mg per insertion, with duration of effect between three and six months depending on metabolic rate and physical activity. The provider's note that Natalie's activity level might shorten duration is consistent with this literature. More active individuals have higher testosterone turnover, and pellet absorption does accelerate with physical exertion (Glaser and Dimitrakakis, 2013, Maturitas).
So the science roughly supports the duration claim and the activity caveat. It does not support a "150 grams" dose, because that would be lethal.
What did they get wrong (or right)?
The "150 grams" figure is wrong, full stop. Whether it was a slip of the tongue by the provider, a mishearing by Natalie, or a transcription error, broadcasting a dosing number that is off by a factor of 1,000 is not a minor mistake. Viewers who are already suspicious of medical authority will treat that number as gospel. Viewers who are research-oriented will be confused. Neither outcome is good.
What Natalie got right: she correctly captured that pellets are inserted subcutaneously in the upper outer gluteal region, that the procedure is genuinely fast (under two minutes is typical), and that discomfort is usually minimal with proper local anesthesia. The pain experience she described, essentially none, is consistent with patient-reported outcomes in Glaser et al. (2009, Maturitas), where the procedure was rated low-discomfort by the majority of participants.
The six-month claim also needs a small correction. Three to four months is more common for women. Six months is on the longer end of the published range and may set unrealistic expectations for some patients.
What should you actually know?
Testosterone pellet therapy in perimenopausal women is a real and increasingly studied intervention, but it sits in a regulatory gray zone. The FDA has not approved any testosterone product specifically for women in the United States, meaning pellets are compounded and not subject to the same manufacturing oversight as approved drugs. That does not make them dangerous by default, but it does mean quality and dosing consistency can vary by pharmacy.
The evidence base is growing. A 2021 systematic review by Islam et al. (Journal of the Endocrine Society) found improvements in sexual function and quality-of-life scores with testosterone therapy in women, but noted that long-term cardiovascular and breast cancer safety data remain limited. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018) recommend against using male-range testosterone doses in women and emphasize monitoring for androgenic side effects like acne, hair loss, and voice changes.
If you are considering pellet therapy, ask your provider for the milligram dose in writing, ask which compounding pharmacy they use, and ask how they monitor your levels. "It lasts six months" is a starting point, not a guarantee.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone pellet insertion on TikTok: what's actually happening, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Testosterone pellet insertion on TikTok: what's actually happening should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video documents a subcutaneous testosterone pellet insertion for a perimenopausal woman, a procedure that involves implanting compounded testosterone pellets in the upper gluteal area under local anesthesia.
FormBlends verdict
The video documents a subcutaneous testosterone pellet insertion for a perimenopausal woman, a procedure that involves implanting compounded testosterone pellets in the upper gluteal area under local anesthesia. The provider states a dose of "150 grams," which is almost certainly a verbal error for 150 milligrams, a figure within the reported female dosing range but on the higher end. Duration of effect for subcutaneous pellets in women typically ranges from three to six months, influenced by metabolic rate and physical activity levels.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video documents a subcutaneous testosterone pellet insertion for a perimenopausal woman, a procedure that involves implanting compounded testosterone pellets in the upper gluteal area under local anesthesia. The provider states a dose of "150 grams," which is almost certainly a verbal error for 150 milligrams, a figure within the reported female dosing range but on the higher end. Duration of effect for subcutaneous pellets in women typically ranges from three to six months, influenced by metabolic rate and physical activity levels.
- The '150 grams' dose stated in the video is almost certainly a verbal error for 150 milligrams. Always get your dose in writing from your provider, in milligrams.
- No FDA-approved testosterone product exists specifically for women in the US. Pellets are compounded drugs, meaning manufacturing standards vary by pharmacy.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The '150 grams' dose stated in the video is almost certainly a verbal error for 150 milligrams. Always get your dose in writing from your provider, in milligrams.
- No FDA-approved testosterone product exists specifically for women in the US. Pellets are compounded drugs, meaning manufacturing standards vary by pharmacy.
- A 2021 systematic review by Islam et al. (Journal of the Endocrine Society) found improvements in sexual function and quality of life with testosterone therapy in women, but flagged limited long-term cardiovascular and breast cancer safety data.
- Duration of effect for pellets in women is typically three to four months, not six. Six months is on the outer edge of the reported range and may not apply to active individuals.
- The Endocrine Society (Bhasin et al., 2018) recommends against male-range testosterone doses in women and advises monitoring for androgenic side effects including acne, hair thinning, and voice changes.
- The procedure itself, fast and low-pain, is accurately depicted. That part of the video is consistent with patient-reported outcomes in clinical literature.
- Physical activity does accelerate pellet absorption, per Glaser and Dimitrakakis (2013, Maturitas), so the provider's caveat about Natalie's active lifestyle was clinically reasonable.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Natalie Murray · TikTok creator
17.5K views on this video
Testosterone pellets being inserted! #DrCharlesRockhead #testosterone #perimenopause #countdownto50
Sources & references
- [1]Davis et al. (2019)
- [2]Glaser et al. (2009)
- [3]Bhasin et al., 2018)
- [4]Glaser and Dimitrakakis, 2013
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Natalie Murray, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.